These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21106135)

  • 1. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
    Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
    Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between amnestic-mild cognitive impairment and early-stage Alzheimer's disease using the Frontal Assessment Battery test.
    Yamao A; Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kasahara H; Nakayama K
    Psychogeriatrics; 2011 Dec; 11(4):235-41. PubMed ID: 22151243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
    Schmand B; Rienstra A; Tamminga H; Richard E; van Gool WA; Caan MW; Majoie CB
    J Alzheimers Dis; 2014; 40(2):409-18. PubMed ID: 24473187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic subcortical hyperintensities in Alzheimer's disease patients from the Sunnybrook Dementia Study: relationships with cognitive dysfunction and hippocampal atrophy.
    McNeely AA; Ramirez J; Nestor SM; Zhao J; Gao F; Kiss A; Stuss DT; Black SE
    J Alzheimers Dis; 2015; 43(3):785-96. PubMed ID: 25114078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients.
    Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K
    Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal complex atrophy in poststroke and mild cognitive impairment.
    Selnes P; Grambaite R; Rincon M; Bjørnerud A; Gjerstad L; Hessen E; Auning E; Johansen K; Almdahl IS; Due-Tønnessen P; Vegge K; Bjelke B; Fladby T
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1729-37. PubMed ID: 26036934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
    Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
    Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
    J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.